FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
MoonLake Immunotherapeutics Stock AnalysisComprehensive stock analysis for MoonLake Immunotherapeutics (MLTX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisMLTX
MLTX
MoonLake Immunotherapeutics
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MLTX
Home🔹Stocks🔹MoonLake Immunotherapeutics

MoonLake Immunotherapeutics

MLTX•NASDAQ

MoonLake Immunotherapeutics

MLTX•NASDAQ
Market cap
$1.55B
Sentiment

Your view on MLTX

Mkt Cap
$1.55B
Sentiment
Your view
MLTX
MoonLake Immunotherapeutics
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MLTX
Company Overview

Overview

What the company does, where it operates, and who runs it.

About MoonLake Immunotherapeutics

Industry
Biotechnology
Sector
Healthcare
CEO
Jorge Santos da Silva
Headquarters
Dorfstrasse 29, Zug, CH
Industry
Biotechnology
Sector
Healthcare
CEO
Jorge Santos da Silva
Headquarters
Dorfstrasse 29, Zug, CH
Description

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News